Hypertension drugs are the class of drugs that are used to treat hypertension i.e., high blood pressure and other related disorders. Hypertension is a health condition where blood pressure increases above a maximum normal level. It also increases the risk of coronary heart disease and ischemic heart disease which are the leading causes of death worldwide. Hypertension leads to various other health problems such as it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of hypertension drug is to lower and control high blood pressure and maintain blood pressure level in brain, heart, kidneys.
Rising cases of patients with hypertension owing to the presence of risk factors such as lifestyles changes, ignoring health problems as well as rise in stress levels are the significant factors boosting the market growth. The hypertension drugs market is anticipated to record a significant CAGR over the forecast period, i.e., 2021-2029. The market is segmented by drug class into alpha blockers, beta blockers, diuretics, vasodilators, angiotensin converting enzyme [ACE] inhibitors, calcium channel blockers, angiotensin II receptor blockers [ARB], renin inhibitors, and others. Among these segments, the segment for diuretics is anticipated to hold the leading share in the market on account of its high preference among majority of patients for hypertension treatment. Further, studies have shown that more than one-third of the adults having hypertension were reported to take diuretics, which is anticipated to drive the growth of the diuretics segment in the global hypertension drugs market. CLICK TO DOWNLOAD SAMPLE REPORT
Hypertension being the most common health disorder among majority of the global population, the need for therapeutic treatment is increasing to control it at an early stage. Moreover, there has been growing prevalence of hypertension over the last few years owing to elevated stress levels and abrupt changes in lifestyle. According to the Centers for Disease Control and Prevention (CDC), in United States, 36,524 people died from essential hypertension and hypertensive renal disease in 2019. Additionally, increased awareness regarding hypertension and its available treatment options attributes to high demand for hypertension drugs. This is anticipated to significantly expand the hypertension drugs market.
The healthcare services all over the world is improving at a fast pace on account of advanced research in development of effective and novel drugs. Many companies are putting emphasis in increasing their efforts toward the discovery of new hypertension drugs in order to manage and control high blood pressure. Furthermore, increasing number of cases of various diseases is resulting in the growing demand for better healthcare services, facilities and equipment at clinics and hospitals. The growing research activities for treatment methods at research laboratories is further anticipated to fuel the healthcare industry. Such factors are anticipated to drive the growth of the global hypertension drugs market over the forecast period.
There is an increase in the number of generic drugs and other substitutes associated for the treatment of hypertension which negatively affects the market growth. Further, presence of some side-effects of these drugs is estimated to hinder the growth of the global hypertension drugs market in the future.
Our in-depth analysis of the global hypertension drugs market includes the following segments:
On the basis of regional analysis, the global hypertension drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market for hypertension drugs in North America is anticipated to hold the largest share in the market on account of the presence of leading market players in the region which manufacture and market hypertension drugs. Moreover, the expertise in rendering prompt and accurate diagnosis of hypertension, favorable reimbursement policies by the government and presence of advanced healthcare infrastructure in this region further increases the product demand. The market in Asia Pacific region is predicted to grow at the highest rate during the forecast period as a result of developing healthcare infrastructure and growing research activities in the region. Additionally, owing to the increasing age as a primary risk factor, the rise in geriatric population, especially in countries such as China, India and Japan are anticipated to raise the demand for hypertension drugs in the region.
The global hypertension drugs market is further classified on the basis of region as follows:
FREQUENTLY ASKED QUESTIONS
Growing awareness for the effects of hypertension on health is one of the major factors driving the market growth.
The market is anticipated to attain a significant CAGR over the forecast period, i.e., 2021-2029
The major players in the market are Janssen Global Services, LLC, Pfizer Inc., Novartis Pharmaceuticals Corporation, Sanofi, Merck & Co., Inc., Abbott, Daiichi Sankyo Company, Ltd., Atnahs Pharma UK Limited, and others.
The company profiles are selected based on the revenues generated from segments, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The hypertension drugs market is majorly segmented by drug class, type, distribution channel and by region.
The diuretics segment, which is a sub-segment of the drug class segment, is anticipated to hold the largest market share during the forecast period.
Concerns for the rising availability of alternatives and generic drugs involved in the treatment of hypertension is one of the major factors estimated to act as barriers to the growth of the market.
Select License Type
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization